TFO

[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID

Find entries where: TFO

is present as a standalone ligand in 1 entries

is present in a polymer sequence 1 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (Quick Screen)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID
Synonyms	TENOFOVIR
Identifiers	[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
Formula	C₉ H₁₄ N₅ O₄ P
Molecular Weight	287.212
Type	DNA LINKING
Isomeric SMILES	C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(O)O
InChI	InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
InChIKey	SGOIRFVFHAKUTI-ZCFIWIBFSA-N

Chemical Details
Formal Charge	0
Atom Count	33
Chiral Atom Count	1
Bond Count	34
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB14126
Name	Tenofovir
Groups	investigational experimental
Description	Tenofovir is an acyclic nucleotide diester analog of adenosine monophosphate.[A37693] In the most strict sense and due to the fact that it presents a phosphate group bound to the nitrogenous base, it is determined as an actual nucleotide analog.[A37693] The antiviral activities of tenofovir were first reported in 1993 and this agent was commercially available since 2008 in the form of [tenofovir disoproxil] and [tenofovir alafenamide] in order to obtain oral bioavailability.[A18473, A178360]
Synonyms	Anhydrous tenofovir Tenofovir (R)-PMPA Tenofovir hydrate Tenofovir anhydrous Tenofovir (anh.) Tenofovir (anhydrous)
Indication	Tenofovir has been shown to be effective against HIV, herpes simplex virus-2, and hepatitis B virus.[A178330] To know more about the specific product indications, please visit the information in the orally available forms of tenofovir, [tenofovir alafenamide] and [tenofovir disoproxil].
Categories	Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiviral Agents Drugs that are Mainly Renally Excreted Enzyme Inhibitors Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor Heterocyclic Compounds, Fused-Ring Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor Nephrotoxic agents Nucleic Acid Synthesis Inhibitors Nucleoside Reverse Transcriptase Inhibitors OAT3/SLC22A8 Substrates Organophosphonates Organophosphorus Compounds P-glycoprotein substrates Purines Reverse Transcriptase Inhibitors Tenofovir and prodrugs
CAS number	147127-20-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Reverse transcriptase/RNaseH	PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...	unknown	inhibitor
Reverse transcriptase	MGVGLSPFLLSQFTSAICSVVRRAFPHCLAFSYMDDVVLGAKTV	unknown	inhibitor
DNA polymerase	MFCAAGGPASPGGKSAARAASGFFAPHNPRGATQTAPPPCRRQNFYNPHL...	unknown	inhibitor
Nucleoside diphosphate kinase A	MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKE...	unknown	substrate
Nucleoside diphosphate kinase B	MANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQ...	unknown	substrate
Adenylate kinase isoenzyme 1	MEEKLKKTKIIFVVGGPGSGKGTQCEKIVQKYGYTHLSTGDLLRSEVSSG...	unknown	substrate
Adenylate kinase 2, mitochondrial	MAPSVPAAEPEYPKGIRAVLLGPPGAGKGTQAPRLAENFCVCHLATGDML...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate
Solute carrier family 22 member 6	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...	unknown	substrate
Solute carrier family 22 member 8	MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...	unknown	substrate
Multidrug resistance-associated protein 4	MLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPE...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682